CTOR

NASDAQStock

Citius Oncology, Inc.

$0.80-0.11 (-12.08%)

52-Week Range

$0.57

$5.29

Key Stats

Market Cap

70.6M

P/E Ratio

—

Dividend Yield

—

Beta

3.04

Volume

392.2K

Avg Volume

497.7K

Performance

-25.41%

-13.33%

-51.08%

YTD

-15.74%

+54.76%

-71.56%

Price Chart

ETF Exposure

CTOR is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.00%	22,013	$21K	$1.27B	0.60%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	18	$26	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	650	$933	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	3	$4	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	370,100	$392K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,946	$3K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	167	$240	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	164,724	$175K	$84.10B	0.05%

About CTOR ETF Exposure

Citius Oncology, Inc. (CTOR) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 70.6M, CTOR is a widely held institutional stock. The stock currently trades at $0.80. Investors can gain exposure to CTOR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CTOR, sorted by portfolio weight.